Explore All 643 Venture Software Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | July 13, 2016 |
| Target | Five AI |
| Sector | Software |
| Investor(s) | Amadeus Capital Partners |
| Deal Type | Venture |
FILTER BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London, United Kingdom.
| Deal Context for Investor | # |
|---|---|
| Overall | 37 of 68 |
| Sector: Software | 8 of 17 |
| Type: Venture | 30 of 59 |
| Country: United Kingdom | 17 of 41 |
| Year: 2016 | 4 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-16 |
Natrox Wound Care
Cambridge, United Kingdom Natrox Wound Care is a MedTech company developing innovative oxygen-based therapies for chronic wound healing. Its flagship product, NATROX® Oxygen Wound Therapy, delivers pure humidified oxygen to treat complex wounds such as diabetic, venous, and non-healing surgical ulcers. Natrox Wound Care was founded in 2003 and is based in Cambridge, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-08 |
Igenomix
Valencia, Spain Igenomix engages in women’s health and reproductive genetic testing services for IVF clinics. The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries. Igenomix was founded in 2011 and headquartered in Valencia, Spain. |
Buy | - |
